Allogene Therapeutics Inc ALLO インサイダー取引

Allogene Therapeutics Inc (ALLO) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-04-21	Ms. Annie YoshiyamaSVP & Corporate Controller	-9.59k	22.14k	売り	2.31	124.52k	-7.15%
2026-03-31	Mr. Benjamin M. BeneskiSenior VP & Chief Technical Officer	-2.87k	7.17k	売り	2.50	195.34k	-1.45%
2026-03-16	Mr. Benjamin M. BeneskiSenior VP & Chief Technical Officer	-4.84k	11.94k	売り	2.47	198.21k	-2.38%
2026-03-16	Dr. David D. ChangCo-Founder, President, CEO & Director	-47.76k	117.97k	売り	2.47	5.95M	-0.80%
2026-03-02	Mr. Benjamin M. BeneskiSenior VP & Chief Technical Officer	-7.13k	18.54k	売り	2.60	203.04k	-3.39%
2026-02-02	Mr. Benjamin M. BeneskiSenior VP & Chief Technical Officer	-7.55k	13.06k	売り	1.73	210.17k	-3.47%
2026-02-02	Dr. David D. ChangCo-Founder, President, CEO & Director	-95.27k	171.48k	売り	1.80	5.84M	-1.61%
2026-02-02	Mr. Geoffrey M. ParkerExec. VP & CFO	-24.00k	42.24k	売り	1.76	1.25M	-1.88%
2026-02-02	Mr. Earl M. DouglasSenior VP, General Counsel, Compliance Officer & Corporate Secretary	-22.90k	40.30k	売り	1.76	564.95k	-3.90%
2026-02-02	Ms. Annie YoshiyamaSVP & Corporate Controller	-4.17k	7.17k	売り	1.72	130.32k	-3.10%
2026-02-02	Dr. Zachary J. RobertsExec. VP of Research & Development and Chief Medical Officer	-35.70k	63.19k	売り	1.77	581.17k	-5.79%
2026-01-21	Dr. Zachary J. RobertsExec. VP of Research & Development and Chief Medical Officer	-26.27k	40.98k	売り	1.56	616.87k	-4.08%
2025-12-18	Mr. Joshua A. KazamCo-Founder & Director	47.70k	0.00	Derivative Exercise and Retained Stock	-	350.76k	15.74%
2025-11-17	Mr. Benjamin M. BeneskiSenior VP & Chief Technical Officer	-786.00	958.92	売り	1.22	217.72k	-0.36%
2025-10-21	Mr. Geoffrey M. ParkerExec. VP & CFO	-36.74k	46.17k	売り	1.26	1.28M	-2.80%
2025-06-10	Ms. Deborah M. MessemerIndependent Director	-36.89k	52.38k	Automatic Disposition	1.42	107.43k	-25.56%